Physician profile
Omar Hasan
NPI 1669602975
$12,427.09
in general payments reported to CMS, 2019-2025
55 companies · $1,879 in 2025
The $1,879 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,893 · 2020: $355 · 2021: $1,030 · 2022: $2,283 · 2023: $2,160 · 2024: $1,827 · 2025: $1,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,751 · Education: $84.99 · Consulting Fee: $15.00 · Entertainment: $14.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,751.28 |
| Education | $84.99 |
| Consulting Fee | $15.00 |
| Entertainment | $14.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,976.14 | 2019-2025 | Mitraclip, Gallant |
| Boston Scientific Corporation | $1,866.86 | 2021-2025 | Watchman Flx, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $1,833.62 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $808.60 | 2019-2025 | |
| Amgen INC. | $542.89 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $492.71 | 2021-2025 | Verquvo |
| Pfizer INC. | $369.67 | 2022-2025 | |
| Penumbra, INC. | $359.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $336.22 | 2021-2025 | Farxiga, Wainua |
| Edwards Lifesciences Corporation | $333.18 | 2019-2021 | |
| Atricure, INC. | $267.93 | 2019-2025 | Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $205.56 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Regeneron Healthcare Solutions, INC. | $202.20 | 2019-2022 | |
| Philips North America LLC | $192.50 | 2022-2025 | Mcot, (Ck4) Mcot, Event |
| E.R. Squibb & Sons, L.L.C. | $165.39 | 2019-2025 | Camzyos, Eliquis |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $164.00 | 2019 | |
| Heartflow, INC. | $155.78 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $152.43 | 2019-2022 | |
| Cook Medical LLC | $138.27 | 2023 | Cook |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.18 | 2019-2024 | Jardiance |
| Cardiva Medical, INC. | $129.75 | 2022-2025 | Optowire, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Biosense Webster, INC. | $122.26 | 2022 | |
| Amarin Pharma, INC. | $109.56 | 2019-2022 | |
| Cordis US Corp. | $98.08 | 2025 | Mynx Control Venous |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.89 | 2019-2023 | Lifevest |
| W. L. Gore & Associates, INC. | $90.92 | 2019-2025 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $90.61 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $88.24 | 2023-2025 | Nexletol |
| Cvrx, INC. | $78.03 | 2024-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $72.07 | 2020-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $71.85 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $69.59 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $67.76 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.51 | 2019-2025 | |
| Althera Pharmaceuticals LLC | $40.54 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $39.75 | 2022-2024 | Optimizer |
| Novo Nordisk INC | $39.01 | 2023-2024 | Ozempic, Rybelsus |
| Cardinal Health 200 LLC | $38.49 | 2019 | |
| Baxter Healthcare | $35.90 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $32.62 | 2024 | |
| Alnylam Pharmaceuticals INC. | $31.03 | 2023-2024 | Amvuttra, Onpattro |
| Daiichi Sankyo INC. | $26.99 | 2022-2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $25.34 | 2025 | Assure Wcd |
| Cardiovascular Systems INC. | $24.77 | 2019-2020 | |
| Vivaquant INC, Dba Rhythm Express | $16.90 | 2025 | Rhythm Express |
| G Medical Diagnostic Services, INC. | $15.30 | 2022 | |
| Amryt Pharma Holdings LTD | $14.80 | 2021 | |
| Opsens INC. | $14.75 | 2023 | Optowire |
| Gilead Sciences, INC. | $14.50 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.39 | 2024 | Arcalyst |
| Lundbeck LLC | $14.22 | 2020 | |
| Irhythm Technologies, INC. | $14.10 | 2024 | Zio Monitor, Zio Xt Patch |
| Otsuka America Pharmaceutical, INC. | $13.11 | 2019 | |
| Azurity Pharmaceuticals, INC. | $12.95 | 2023 | Edarbyclor |
| Mylan Specialty L.P. | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.